Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Alekseev, Oleg M ^a   Richardson, Richard T ^a   Tsuruta, James K ^b   O'Rand, Michael G ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; PROTEIN P21; TESTIS EMBRYO FORM OF NUCLEAR AUTOANTIGENIC SPERM PROTEIN; UNCLASSIFIED DRUG; AUTOANTIGEN; NASP PROTEIN, HUMAN; NUCLEAR PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HELA CELL; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ADENOCARCINOMA; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; GENE SILENCING; GENETICS; HUMAN; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

LENTIVIRUS;

ADENOCARCINOMA; APOPTOSIS; AUTOANTIGENS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HISTONE CHAPERONES; HUMANS; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING;

EID: 79955092713     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-50     Document Type: Article

References (57)

1. Osakabe A, Tachiwana H, Matsunaga T, Shiga T, Nozawa RS, Obuse C, Kurumizaka H. Nucleosome formation activity of human somatic nuclear autoantigenic sperm protein (sNASP). J Biol Chem 2010, 285(16):11913-11921. 10.1074/jbc.M109.083238, 2852928, 20167597.
2. Richardson RT, Batova IN, Widgren EE, Zheng LX, Whitfield M, Marzluff WF, O'Rand MG. Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. J Biol Chem 2000, 275(39):30378-30386. 10.1074/jbc.M003781200, 10893414.
3. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 2004, 116(1):51-61. 10.1016/S0092-8674(03)01064-X, 14718166.
4. Wang H, Walsh STR, Parthun MR. Expanded binding specificity of the human histone chaperone NASP. Nucleic Acids Res 2008, 36(18):5763-5772. 10.1093/nar/gkn574, 2566879, 18782834.
5. Finn RM, Browne K, Hodgson KC, Ausio J. sNASP, a histone H1-specific eukaryotic chaperone dimer that facilitates chromatin assembly. Biophys J 2008, 95(3):1314-1325. 10.1529/biophysj.108.130021, 2479616, 18456819.
6. Welch J, O'Rand M. Characterization of a sperm-specific nuclear autoantigenic protein. II. Expression and localization in the testis. Biol Reprod 1990, 43(4):569-578. 10.1095/biolreprod43.4.569, 2289011.
7. Kleinschmidt J, Fortkamp E, Krohne G, Zentgraf H, Franke W. Co-existence of two different types of soluble histone complexes in nuclei of Xenopus laevis oocytes. J Biol Chem 1985, 260(2):1166-1176.
8. Kleinschmidt JA, Seiter A. Identification of domains involved in nuclear uptake and histone binding of protein N1 of Xenopus laevis. EMBO J 1988, 7(6):1605-1614. 457143, 3168999.
9. Alekseev OM, Bencic DC, Richardson RT, Widgren EE, O'Rand MG. Overexpression of the linker histone-binding protein tNASP affects progression through the cell cycle. J Biol Chem 2003, 278(10):8846-8852. 10.1074/jbc.M210352200, 12509435.
10. Alekseev OM, Richardson RT, Alekseev O, O'Rand MG. Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP. Reprod Biol Endocrinol 2009, 7(1):45. 10.1186/1477-7827-7-45, 2686705, 19439102.
11. Richardson RT, Alekseev OM, Grossman G, Widgren EE, Thresher R, Wagner EJ, Sullivan KD, Marzluff WF, O'Rand MG. Nuclear Autoantigenic Sperm Protein (NASP), a linker histone chaperone that is required for cell proliferation. J Biol Chem 2006, 281(30):21526-21534. 10.1074/jbc.M603816200, 16728391.
12. Sun Y, Li H, Liu Y, Mattson MP, Rao MS, Zhan M. Evolutionarily conserved transcriptional co-expression guiding embryonic stem cell differentiation. PLoS ONE 2008, 3(10):e3406. 10.1371/journal.pone.0003406, 2566604, 18923680.
13. Alekseev OM, Richardson RT, O'Rand MG. Linker histones stimulate HSPA2 ATPase activity through NASP binding and inhibit CDC2/cyclin B1 complex formation during meiosis in the mouse. Biol Reprod 2009, 81(4):739-748. 10.1095/biolreprod.109.076497, 2754887, 19553603.
14. Nakatani Y, Ray-Gallet D, Quivy J, Tagami H, Almouzni G. Two distinct nucleosome assembly pathways: dependent or independent of DNA synthesis promoted by histone H3.1 and H3.3 complexes. Cold Spring Harb Symp Quant Biol 2004, 69:273-280. 10.1101/sqb.2004.69.273, 16117659.
15. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316(5828):1160-1166. 10.1126/science.1140321, 17525332.
16. Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Nowak J, Ye B, Nahhas FA, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006, 66(2):1181-1190. 10.1158/0008-5472.CAN-04-2962, 2546578, 16424057.
17. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752. 10.1038/35021093, 10963602.
18. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415(6871):530-536.
19. Martin KJ, Patrick DR, Bissell MJ, Fournier MV. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE 2008, 3(8):e2994. 10.1371/journal.pone.0002994, 2500166, 18714348.
20. Maslikowski BM, Neel BD, Wu Y, Wang L, Rodrigues NA, Gillet G, Bedard PA. Cellular processes of v-Src transformation revealed by gene profiling of primary cells - implications for human cancer. BMC Cancer 2010, 10:41. 10.1186/1471-2407-10-41, 2837010, 20152043.
21. Amundson SA, Do KT, Vinikoor LC, Lee RA, Koch-Paiz CA, Ahn J, Reimers M, Chen Y, Scudiero DA, Weinstein JN, Trent JM, Bittner ML, Meltzer PS, Fornace AJ. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the national cancer institute anticancer drug screen. Cancer Res 2008, 68(2):415-424. 10.1158/0008-5472.CAN-07-2120, 18199535.
22. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, Rhim JS. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. Carcinogenesis 1996, 17(8):1641-1646. 10.1093/carcin/17.8.1641, 8761420.
23. Efeyan A, Ortega-Molina A, Velasco-Miguel S, Herranz D, Vassilev LT, Serrano M. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res 2007, 67(15):7350-7357. 10.1158/0008-5472.CAN-07-0200, 17671205.
24. Rödel F, Franz S, Sheriff A, Gaipl U, Heyder P, Hildebrandt G, Schultze-Mosgau S, Voll RE, Herrmann M. The CFSE distribution assay is a powerful technique for the analysis of radiation-induced cell death and survival on a single-sell level. Strahlenther Onkol 2005, 181(7):456-462.
25. Broad Institute. [last accessed on April 12, 2011]., http://www.broadinstitute.org/rnai/trc/lib
26. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006, 124(6):1283-1298. 10.1016/j.cell.2006.01.040, 16564017.
27. Addgene. [last accessed on April 12, 2011]., http://www.addgene.org/pgvec1
28. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005, 307(5712):1098-1101. 10.1126/science.1106148, 15718470.
29. PCR Array Data Analysis. [last accessed on April 12, 2011]., http://www.sabiosciences.com/pcr/arrayanalysis.php
30. Aherne W, Maloney A, Prodromou C, Rowlands MG, Hardcastle A, Boxall K, Clarke P, Walton MI, Pearl L, Workman P. Assays for HSP90 and inhibitors. Methods Mol Med 2003, 85:149-161.
31. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines. Prostate 1996, 29(6):386-394. 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6, 8977636.
32. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92(20):9363-9367. 10.1073/pnas.92.20.9363, 40985, 7568133.
33. Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A, Scambia G. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Clin Cancer Res 2003, 9(12):4324-4331.
34. Jeruc J, Vizjak A, Rozman B, Ferluga D. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis. Am J Kidney Dis 2006, 48(3):410-418. 10.1053/j.ajkd.2006.05.019, 16931214.
35. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J, Jaattela M. Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 2005, 19(5):570-582. 10.1101/gad.305405, 551577, 15741319.
36. Nylandsted J, Brand K, Jaattela M. Heat shock protein 70 Is required for the survival of cancer cells. Ann N Y Acad Sci 2000, 926:122-125. Mechanisms of cell death II: the third annual conference of the international cell death society, 10.1111/j.1749-6632.2000.tb05605.x, 11193027.
37. Lin Q, Sirotkin A, Skoultchi AI. Normal spermatogenesis in mice lacking the testis-specific linker histone H1t. Mol Cell Biol 2000, 20(6):2122-2128. 10.1128/MCB.20.6.2122-2128.2000, 110828, 10688658.
38. Bénard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 2003, 21(3):182-191.
39. Post SM, Quintas-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. p53-dependent senescence delays Eμ-myc-induced B-cell lymphomagenesis. Oncogene 2010, 29(9):1260-1269. 10.1038/onc.2009.423, 2903442, 19935700.
40. Oh TJ, Kim CJ, Woo SK, Kim TS, Jeong DJ, Kim MS, Lee S, Cho HS, An S. Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses. J Clin Microbiol 2004, 42(7):3272-3280. 10.1128/JCM.42.7.3272-3280.2004, 446283, 15243092.
41. Hoppe-Seyler F, Butz K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J Virol 1993, 67(6):3111-3117. 237648, 8388491.
42. Carroll AG, Voeller HJ, Sugars L, Gelmann EP. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 1993, 23(2):123-134. 10.1002/pros.2990230206, 8104329.
43. Muhlbauer KR, Grone HJ, Ernst T, Grone E, Tschada R, Hergenhahn M, Hollstein M. Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Br J Cancer 2003, 89(4):687-690. 10.1038/sj.bjc.6601164, 2376923, 12915879.
44. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJY, Shridhar V, De Bartolomeis A, Esposito V, Giuliano MT, Steinberg SM, Levine AS, Giordano A, Pass HI. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997, 3(8):908-912. 10.1038/nm0897-908, 9256284.
45. Wade Harper J, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75(4):805-816. 10.1016/0092-8674(93)90499-G, 8242751.
46. Deng C, Zhang P, Wade Harper J, Elledge SJ, Leder P. Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995, 82(4):675-684. 10.1016/0092-8674(95)90039-X, 7664346.
47. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995, 377(6549):552-557. 10.1038/377552a0, 7566157.
48. Gartel AL, Najmabadi F, Goufman E, Tyner AL. A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription. Oncogene 2000, 19(7):961-964. 10.1038/sj.onc.1203411, 10702805.
49. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009, 9(6):400-414. 10.1038/nrc2657, 2722839, 19440234.
50. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20(19):2390-2400. 10.1038/sj.onc.1204383, 11402335.
51. Alekseev OM, Widgren EE, Richardson RT, O'Rand MG. Association of NASP with HSP90 in mouse spermatogenic cells: stimulation of ATPase activity and transport of linker histones into nuclei. J Biol Chem 2005, 280(4):2904-2911. 10.1074/jbc.M410397200, 15533935.
52. Sancho M, Diani E, Beato M, Jordan A. Depletion of human histone H1 variants uncovers specific roles in gene expression and cell growth. PLoS Genet 2008, 4(10):e1000227. 10.1371/journal.pgen.1000227, 2563032, 18927631.
53. Lu Z, Sittman D, Brown D, Munshi R, Leno G. Histone H1 modulates DNA replication through multiple pathways in Xenopus egg extract. J Cell Sci 1997, 110(21):2745-2758.
54. Fan Y, Nikitina T, Zhao J, Fleury TJ, Bhattacharyya R, Bouhassira EE, Stein A, Woodcock CL, Skoultchi AI. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 2005, 123(7):1199-1212. 10.1016/j.cell.2005.10.028, 16377562.
55. Eddy E. Role of heat shock protein HSP70-2 in spermatogenesis. Rev Reprod 1999, 4(1):23-30. 10.1530/ror.0.0040023, 10051099.
56. Zhu D, Dix D, Eddy E. HSP70-2 is required for CDC2 kinase activity in meiosis I of mouse spermatocytes. Development 1997, 124(15):3007-3014.
57. Daugaard M, Jäättelä M, Rohde M. Hsp70-2 is required for tumor cell growth and survival. Cell Cycle 2005, 4(7):877-880. 10.4161/cc.4.7.1838, 15970673.